NIH-funded research R21 grant

Using machine learning to identify heart disease risk in childhood cancer survivors

Official title: Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors

Funded at Fred Hutchinson Cancer Center · NIH-10878937 · Data updated 2026-11-12

This study is looking at how smart computer programs can help doctors find heart problems earlier in childhood cancer survivors who have had certain treatments, so they can get better care and stay healthier.

More Cancer Survivors research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$214,010
NIH project number5R21CA277746-02
Project IDNIH-10878937 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are childhood cancer survivors who have received anthracycline chemotherapy or chest radiation and are at risk for cardiomyopathy.

Less likely to help

Patients who have not undergone treatment for childhood cancer or those without a history of anthracycline use or chest radiation may not benefit from this research.

What this research studies

This research investigates how machine learning can enhance the identification of cardiomyopathy risk in survivors of childhood cancer, particularly those who have undergone treatment with anthracycline chemotherapy and chest radiation. The study aims to improve upon traditional 2D echocardiography methods, which can be limited by variability and sensitivity issues. By leveraging advanced AI techniques, the research seeks to provide more accurate and earlier detection of heart issues, potentially leading to better management and outcomes for these patients.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and intervention for heart disease in childhood cancer survivors, improving their long-term health outcomes.

How similar studies have gone: Previous research has shown promise in using machine learning for similar applications in cardiology, indicating potential for success in this novel approach.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Chow, Eric Jessen — Fred Hutchinson Cancer Center
  • Study coordinator: Chow, Eric Jessen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.